ALCOX:EPA
NicOx SA
0,31 €
arrow_downward
-0,97%(-0,0030) 1D
12 қаз., 11:42:18 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
0,31 €
High
0,31 €
Low
0,31 €
Mkt. cap
29,76 млн
Avg. vol.
164,58 м.
Volume
46,46 мың
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 млн
No. of employees
10
Open
0,31 €
High
0,31 €
Low
0,31 €
Mkt. cap
29,76 млн
Avg. vol.
164,58 м.
Volume
46,46 мың
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 млн
No. of employees
10
News stories
From web sources and news partners
Yahoo Finance
·
1 сағат бұрын
Why Are Nasdaq Futures Rising Premarket? MU, IREN, SLS, NIO, ASTS, WFF Stocks In Focus
Sahi
·
41 минут бұрын
Black Box Shows Interest In Nasdaq Listed Aeries Technology Reporting $70 Million FY26 Revenue
The Motley Fool
·
5 минут бұрын
Vanguard's S&P 500 Fund Has Raised Its Payout 71% Since 2016. Its Yield Has Nearly Halved.
Bloomberg.com
·
11 сағат бұрын
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, Франция
Sector-
Websitenicox.com